Role of interferon in clinical practice

L. Sreter, J. Fehér

Research output: Contribution to journalArticle

Abstract

Interferons are currently the most widely used biological response modifiers. They are of high clinical value in haematological malignancies (chronic myelogenous leukaemia, multiple myeloma, non-Hodgkin lymphoma), in solid tumours (malignant melanoma, hypernephroma, pancreas neoplasms, carcinoid tumours, Kaposi's sarcoma, glioma, in ovarium, cervix and bladder carcinoma, and in basalioma) an in infectious diseases (chronic hepatitis B, chronic non-A/non-B hepatitis, chronic delta hepatitis, AIDS, Papova virus and Rhinovirus infections, leishmaniasis, leprosy) and some other conditions. Although the mechanism of action of interfersons has not been explained in every detail these agents are promising therapeutic means in a number of diseases.

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalTherapia Hungarica
Volume39
Issue number4
Publication statusPublished - 1991

Fingerprint

Chronic Hepatitis D
Rhinovirus
Leishmaniasis
Kaposi's Sarcoma
Chronic Hepatitis B
Carcinoid Tumor
Immunologic Factors
Virus Diseases
Hematologic Neoplasms
Leprosy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Multiple Myeloma
Pancreatic Neoplasms
Renal Cell Carcinoma
Cervix Uteri
Glioma
Non-Hodgkin's Lymphoma
Interferons
Hepatitis
Communicable Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of interferon in clinical practice. / Sreter, L.; Fehér, J.

In: Therapia Hungarica, Vol. 39, No. 4, 1991, p. 159-166.

Research output: Contribution to journalArticle

Sreter, L & Fehér, J 1991, 'Role of interferon in clinical practice', Therapia Hungarica, vol. 39, no. 4, pp. 159-166.
Sreter, L. ; Fehér, J. / Role of interferon in clinical practice. In: Therapia Hungarica. 1991 ; Vol. 39, No. 4. pp. 159-166.
@article{e634934c3c9740d580dda907e417a524,
title = "Role of interferon in clinical practice",
abstract = "Interferons are currently the most widely used biological response modifiers. They are of high clinical value in haematological malignancies (chronic myelogenous leukaemia, multiple myeloma, non-Hodgkin lymphoma), in solid tumours (malignant melanoma, hypernephroma, pancreas neoplasms, carcinoid tumours, Kaposi's sarcoma, glioma, in ovarium, cervix and bladder carcinoma, and in basalioma) an in infectious diseases (chronic hepatitis B, chronic non-A/non-B hepatitis, chronic delta hepatitis, AIDS, Papova virus and Rhinovirus infections, leishmaniasis, leprosy) and some other conditions. Although the mechanism of action of interfersons has not been explained in every detail these agents are promising therapeutic means in a number of diseases.",
author = "L. Sreter and J. Feh{\'e}r",
year = "1991",
language = "English",
volume = "39",
pages = "159--166",
journal = "Therapia Hungarica",
issn = "0133-3909",
number = "4",

}

TY - JOUR

T1 - Role of interferon in clinical practice

AU - Sreter, L.

AU - Fehér, J.

PY - 1991

Y1 - 1991

N2 - Interferons are currently the most widely used biological response modifiers. They are of high clinical value in haematological malignancies (chronic myelogenous leukaemia, multiple myeloma, non-Hodgkin lymphoma), in solid tumours (malignant melanoma, hypernephroma, pancreas neoplasms, carcinoid tumours, Kaposi's sarcoma, glioma, in ovarium, cervix and bladder carcinoma, and in basalioma) an in infectious diseases (chronic hepatitis B, chronic non-A/non-B hepatitis, chronic delta hepatitis, AIDS, Papova virus and Rhinovirus infections, leishmaniasis, leprosy) and some other conditions. Although the mechanism of action of interfersons has not been explained in every detail these agents are promising therapeutic means in a number of diseases.

AB - Interferons are currently the most widely used biological response modifiers. They are of high clinical value in haematological malignancies (chronic myelogenous leukaemia, multiple myeloma, non-Hodgkin lymphoma), in solid tumours (malignant melanoma, hypernephroma, pancreas neoplasms, carcinoid tumours, Kaposi's sarcoma, glioma, in ovarium, cervix and bladder carcinoma, and in basalioma) an in infectious diseases (chronic hepatitis B, chronic non-A/non-B hepatitis, chronic delta hepatitis, AIDS, Papova virus and Rhinovirus infections, leishmaniasis, leprosy) and some other conditions. Although the mechanism of action of interfersons has not been explained in every detail these agents are promising therapeutic means in a number of diseases.

UR - http://www.scopus.com/inward/record.url?scp=0026321789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026321789&partnerID=8YFLogxK

M3 - Article

C2 - 1725832

AN - SCOPUS:0026321789

VL - 39

SP - 159

EP - 166

JO - Therapia Hungarica

JF - Therapia Hungarica

SN - 0133-3909

IS - 4

ER -